Aquamatrix

AquaMatrix Biomedical was a biotechnology company focused on the development and commercialization of synthetic extracellular matrix (sECM) technology for regenerative medicine and wound care. The company's core technology utilized self-assembling peptides to create a scaffold that mimics the natural extracellular matrix, promoting cell growth and tissue regeneration. Its lead product, AquaMatrix, was designed for the treatment of chronic and hard-to-heal wounds, including diabetic foot ulcers and venous leg ulcers. By providing a synthetic, biocompatible environment, the technology aimed to accelerate healing processes in patients with compromised tissue repair mechanisms.